Primary Health Properties PLC

Director's Dealing • May 26, 2020

National Storage Mechanism | Additional information

RNS Number : 9692N

Primary Health Properties PLC

26 May 2020

Primary Health Properties PLC

Director shareholding

The Company has been advised that the following information relating to the transaction below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation

1	Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")
(a)	Name	Harry Hyman
2	Reason for the notification
(a)	Position/status	Managing Director
(b)	Initial notification/ amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)	Name of Entity	Primary Health Properties PLC
(b)	Legal Entity Identifier	213800Y5CJHXOATK7X11
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a)	Description of the financial instrument	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of the transaction	Acquisition in scrip dividend scheme
(c)	Price(s) and volume(s)	Price(s)		Volume(s)
£1.555		430
(d)	Aggregated information Aggregated volume price	Single transaction £668.73
(e)	Date of transaction	22 May 2020
(f)	Place of transaction	London Stock Exchange (xlon)
(a)	Description of the financial instrument	Ordinary shares of 12.5p ISIN: GB00BYRJ5J14
(b)	Nature of the transaction	Purchase by ISA in dividend re-investment plan
(c)	Price(s) and volume(s)	Price(s)	Volume
£1.563	1,465
(d)	Aggregated information Aggregated volume price	Single transaction £2,289.65
(e)	Date of transaction	22 May 2020
(f)	Place of transaction	London Stock Exchange (xlon)

For further information:

Primary Health Properties PLC

Paul Wright, Nexus Management Services Limited, Company Secretary

+44(0) 20 7451 7050

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDUIGDDGGL